NEW YORK, Feb. 27 - Orchid BioSciences on Wednesday said it has pocketed approximately $20 million in a special stock offering announced last week.
Orchid said it sold 8 million shares of common stock that were offered through a prospectus supplement in-line with the company's shelf-registration.